ZOLL R Series Monitor Defibrillator Rev J - Manual (Page 380)

C HAPTER 1 G ENERAL I NFORMATION
1–10 www.zoll.com 9650-0912-01 Rev. K
Pediatric Pacing
Pacing can be performed on pediatric patients weighing 55 lb. (25 kg) or less using ZOLL
pediatric hands-free therapy electrodes. Prolonged pacing (in excess of 30 minutes),
particularly in neonates, can cause burns. Periodic inspection of the underlying skin is
recommended.
Intended Use — SpO
2
Monitoring
The R Series pulse oximeter, with the Masimo
®
SET
®
technology and the LNCS
®
series of
oximeter sensors, is indicated for the continuous, noninvasive monitoring of arterial oxygen
saturation (SpO
2
) and pulse rate during both no motion and patient motion conditions for adult
patients, and no motion conditions for pediatric and neonatal patients in a hospital or
prehospital environment.
Intended Use — EtCO
2
Monitoring
The ZOLL R Series EtCO
2
option with Respironics Novametrix technology is indicated for the
continuous noninvasive monitoring of end tidal carbon dioxide (EtCO
2
) and respiration rate in
patients requiring ventilator support, in-hospital transport, or anesthesia.
This option uses the CAPNOSTAT 5 Mainstream CO
2
sensor attached to an airway adapter that
connects to an endotracheal tube, mask or disposable mouthpiece.
The R Series EtCO
2
option is designed to monitor adult, pediatric, and neonatal patients.
The following substances can influence CO
2
measurements made with the CAPNOSTAT 5 CO
2
sensor:
• elevated oxygen levels
• nitrous oxide
• halogenated agents
The R Series EtCO
2
option provides settings for high oxygen and/or nitrous oxide
compensation. Halogenated anesthetic agents alter CO
2
readings, but the R Series unit will
monitor CO
2
within specifications when these agents are present at normal clinical levels. The
presence of Desflurane in the exhaled breath beyond normal values (5%) may positively bias
measured carbon dioxide values by up to an additional 3 mmHg.
The R Series EtCO
2
option is intended for use only with the ZOLL/Respironics Novametrix
CAPNOSTAT 5 Mainstream CO
2
Sensor and mainstream airway adapters.
The R Series EtCO
2
option can be used on adult patients (21 years of age and older) and on
pediatric patients, as described in the following table:
Pediatric Subpopulation Approximate Age Range
Newborn (neonate) Birth to 1 month of age
Infant 1 month to 2 years of age
Child 2 to 12 years of age
Adolescent 12-21 years of age